Study on Ustekinumab for IBD Patients Switching from Anti-TNFα Due to Psoriasis
A study is investigating the outcomes of children with Crohn's disease or ulcerative colitis who switch from anti-TNFα therapy to ustekinumab due to paradoxical psoriasis.